Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin

PURPOSE: To identify effective metabolicinhibitors to suppress the aggressive growth of pancreatic ductal adenocarcinoma (PDAC), we explored the in vivo antitumor efficacy of metabolic inhibitors, as single agents, in a panel of patient-derived PDAC xenograft models (PDX) and investigated whether ge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Rajeshkumar, N.V., Yabuuchi, Shinichi, Pai, Shweta G., De Oliveira, Elizabeth, Kamphorst, Jurre J., Rabinowitz, Joshua D., Tejero, Héctor, Al-Shahrour, Fátima, Hidalgo, Manuel, Maitra, Anirban, Dang, Chi V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6540110/
https://ncbi.nlm.nih.gov/pubmed/28611197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-1115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados